Fibrinogen and D-dimer variances and anticoagulation recommendations in Covid-19: current literature review
SUMMARY INTRODUCTION Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a newly described virus responsible for the outbreak of the coronavirus disease 2019 (Covid-19), named by the World Health Organization (WHO) in February/2020. Patients with Covid-19 have an incidence of acute respiratory distress syndrome (ARDS) of 15.9-29% and sepsis is observed in all deceased patients. Moreover, disseminated intravascular coagulation (DIC) is one of the major underlying causes of death among these patients. In patients with DIC, there is a decrease in fibrinogen and an increase in D-dimer levels. Some studies have shown that fibrinogen and one of its end products, D-dimer, might have a predictive value for mortality in patients with non-Covid sepsis secondary to complications of DIC. Therefore, anticoagulation, considering its mortality benefits in cases of non-Covid sepsis, may also have an important role in the treatment of Covid-19. METHODS We reviewed the literature of all studies published by April 2020 on patients infected with Covid-19. Our review was limited to D-dimer and fibrinogen changes and anticoagulation recommendations. RESULTS Anticoagulation therapy can be started following the DIC diagnosis in Covid-19 patients despite the bleeding risks. In addition, the current evidence suggests a routine use of anticoagulation, particularly in patients with higher D-dimer levels (> 3.0 μg/mL). CONCLUSION Covid-19 is a systemic, hypercoagulable disease requiring more studies concerning treatment. Aanticoagulation is still an issue to be studied, but D-dimer rise and disease severity are the indicative factors to start treatment as soon as possible.
Main Authors: | Hayıroğlu,Mert İlker, Çınar,Tufan, Tekkeşin,Ahmet İlker |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Associação Médica Brasileira
2020
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302020000600842 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mean serum D-dimer level to predict in-hospital mortality in COVID-19
by: Hayıroğlu,Mert İlker, et al.
Published: (2021) -
COVID-19 and acute myocarditis: current literature review and diagnostic challenges
by: Çınar,Tufan, et al.
Published: (2020) -
Review of the current literature regarding cardiac adverse events following COVID-19 vaccination
by: Çınar,Tufan, et al.
Published: (2021) -
Comment on: “Comparison of C-reactive protein and C-reactive protein-to-albumin ratio in predicting mortality among geriatric coronavirus disease 2019 patients”
by: Çınar,Tufan, et al.
Published: (2022) -
Predictors of left atrial thrombus in acute ischemic stroke patients without atrial fibrillation: A single-center cross-sectional study
by: Cinar,Tufan, et al.
Published: (2020)